Leeor BenPeretz - Cellebrite Chief Officer
| CLBTWDelisted Stock | USD 5.15 0.44 7.87% |
Insider
Leeor BenPeretz is Chief Officer of Cellebrite DI Equity
| Age | 48 |
| Phone | 972 73 394 8000 |
| Web | https://www.cellebrite.com |
Cellebrite Management Efficiency
The company has return on total asset (ROA) of 0.0639 % which means that it generated a profit of $0.0639 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (17.6851) %, meaning that it generated substantial loss on money invested by shareholders. Cellebrite's management efficiency ratios could be used to measure how well Cellebrite manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Max Levy | Sonida Senior Living | 33 | |
| Wendy Hayes | Ihuman Inc | 50 | |
| Joel Morales | Alvotech | 46 | |
| Noah Beren | Sonida Senior Living | N/A | |
| Byron CPA | SunLink Health Systems | 74 | |
| Mark Levick | Alvotech | 60 | |
| Douglas Jones | Neogen | 54 | |
| Carole Burnell | Sonida Senior Living | 51 | |
| Michael Fryar | Sonida Senior Living | 46 | |
| Jay Reed | Sonida Senior Living | N/A | |
| RoseMarie Ohlsson | Alvotech | N/A | |
| Yufeng Chi | Ihuman Inc | 53 | |
| Robert Hollister | Sonida Senior Living | 64 | |
| CPA CPA | Sonida Senior Living | N/A | |
| Sigridur Gudlaugsdottir | Alvotech | N/A | |
| Iqbal LLB | Centessa Pharmaceuticals PLC | 43 | |
| Xuenan Li | Ihuman Inc | N/A | |
| Benjamin Harris | Sonida Senior Living | 43 | |
| David Grainger | Centessa Pharmaceuticals PLC | 55 | |
| Thomas Templeman | Centessa Pharmaceuticals PLC | 64 | |
| Anil Okay | Alvotech | 38 | |
Management Performance
| Return On Equity | -17.69 | |||
| Return On Asset | 0.0639 |
Cellebrite DI Equity Leadership Team
Elected by the shareholders, the Cellebrite's board of directors comprises two types of representatives: Cellebrite inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cellebrite. The board's role is to monitor Cellebrite's management team and ensure that shareholders' interests are well served. Cellebrite's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cellebrite's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yossi Carmil, CEO Director | ||
| Thomas Hogan, Executive Chairman | ||
| Zohar TadmorEilat, Chief Officer | ||
| Osnat Tirosh, Chief Officer | ||
| Ori Nurick, Ex Management | ||
| David Gee, Chief Officer | ||
| Adam Jaffe, VP Communications | ||
| Ayala Shapira, General Counsel | ||
| Anat Paran, Executive Services | ||
| Marque Teegardin, President Management | ||
| Ronnen Armon, Chief Officer | ||
| Arnon Zilberman, Executive Operations | ||
| Andrew Kramer, Vice Relations | ||
| Dana Gerner, Chief Officer | ||
| Paul Battaglia, Sr America | ||
| Alon Klomek, Chief Officer | ||
| Lisa Cole, Chief Officer | ||
| Leeor BenPeretz, Chief Officer | ||
| Mark Gambill, Chief Officer | ||
| Marcus Jewell, Global Officer |
Cellebrite Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cellebrite a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -17.69 | |||
| Return On Asset | 0.0639 | |||
| Profit Margin | (0.29) % | |||
| Operating Margin | 0.13 % | |||
| Number Of Shares Shorted | 356.81 K | |||
| Price To Earning | 12.50 X | |||
| Revenue | 325.11 M | |||
| Gross Profit | 219.91 M | |||
| EBITDA | 43.29 M | |||
| Net Income | (81.1 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Cellebrite Stock
If you are still planning to invest in Cellebrite DI Equity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cellebrite's history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |